EUROPEAN
CURRICULUM VITAE
FORMAT
PERSONAL INFORMATION
Name
Address
LOMBARDI GIUSEPPE
VENETO INSTITUTE OF ONCOLOGY
MEDICAL ONCOLOGY 1 UNIT
VIA GATTAMELATA 64
35128 PADUA, ITALY
Telephone
+39-049-8215910
Fax
+39-049-8215900
E-mail
Nationality
Date of birth
giuseppe.lombardi@ioveneto.it
Italian
MARCH, 13TH, 1980
WORK EXPERIENCE
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
February 2010-present
Medical Oncology 1 Unit
Istituto Oncologico Veneto, IRCCS, Padova
Public Hospital
Medical Oncologist with contract
Medical Treatment of Cancer Patients with Brain Tumors and Hepatocellular Carcinoma
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
January 2011- March 2014
University of Padua Public Hospital
PhD on Oncology and Oncological Surgery
Research of a biomarker in glioma patients
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
December 2012-February 2013
Department of Neuro-Oncology
Hospital Salpetriere, University of Paris VI, Paris (France)
Public Hospital
Fellow
Clinical and Research Activity on Brain Tumors
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
January 2009 – March 2009
Memorial Sloan Kettering Cancer Center – New York (USA)
Neuro- Oncology
Fellow
Research project on Brain Tumors
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
•
January 2006 – January 2010
Resident in Medical Oncology
Padua University
Assistance in medical management and clinical research in solid tumors
RESEARCH EXPERIENCE
• Dates (from – to)
• Name and address of Organization
• Occupation or position held
• Main activities and responsibilities
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
2010-present
Industry Sponsored Trials or Academic trials (European Organization for Research and
Treatment of Cancer-EORTC)
Principal Investigator or Co-Investigator for more than 20 trials (Industry-sponsored or
Academic) dealing with Brain Tumors, Gastrointestinal Tumors, Hepatocellular
Carcinoma,Genitourinary Cancer.
January 2011- March 2014
University of Padua Public Hospital
PhD on Oncology and Oncological Surgery
Research of a biomarker in glioma patients
EDUCATION AND TRAINING
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
January 2011- March 2014
University of Padua Public Hospital
PhD on Oncology and Oncological Surgery
Research of a biomarker in glioma patients
• Dates (from – to)
• Name and type of organisation
providing education and training
• Principal subjects/occupational
skills covered
• Title of qualification awarded
2006-2010
Padova University
• Dates (from – to)
• Name and type of organisation
providing education and training
• Principal subjects/occupational
skills covered
• Title of qualification awarded
2004
Padova University
Medical Oncology
Specialty in Medical Oncology
Medicine
Degree in Medicine (M.D.-Medical Doctor)
ACADEMIC POSITION
• Dates (from – to)
• Name and address of employer
• Type of business or sector
• Occupation or position held
• Main activities and responsibilities
January 2011- March 2014
University of Padua Public Hospital
PhD on Oncology and Oncological Surgery
Research of a biomarker in glioma patients
PERSONAL SKILLS
AND COMPETENCES
Acquired in the course of life and career
but not necessarily covered by formal
certificates and diplomas.
MOTHER TONGUE
ITALIAN
OTHER LANGUAGES
• Reading skills
• Writing skills
• Verbal skills
ENGLISH
EXCELLENT
EXCELLENT
GOOD
OTHER LANGUAGES
• Reading skills
• Writing skills
• Verbal skills
ORGANISATIONAL SKILLS
AND COMPETENCES
Coordination and administration of people,
projects and budgets; at work, in voluntary
work (for example culture and sports) and at
home, etc.
TECHNICAL SKILLS
AND COMPETENCES
With computers, specific kinds of equipment,
machinery, etc.
ANNEXES
FRENCH
GOOD
GOOD
GOOD
MANAGEMENT OF CANCER PATIENTS WITHIN MULTIDISCIPLINARY TEAMS
WRITING OF RESEARCH PROJECTS
CONDUCTION OF CLINICAL TRIALS (PHASE II, III AND IV)
OFFICE PACKAGE
RESEARCHES IN PUBLIC DATABASES
STATISTICAL SOFTWARE (SPSS )
ENDNOTE AND REFWORKS SOFTWARE (FOR PAPER EDITING)
EDITORIAL MEMBER
BOOK
SCIENTIFIC PUBLICATIONS
SCIENTIFIC AFFILIATIONS
Editorial Member
Books
Scientific Publications
Editorial Member of “Case Repoort in Urology” and “jJournal of Tumor”
Editorial Member of “Epatoncologia” (www.epatoncologia.it)
F. Zustovich, G. Lombardi. Glioblastoma Patients: Chemotherapy with Cisplatin, Temozolomide
and Thalidomide; M.A. Hayat (ed.), Tumors of the Central Nervous System, Volume 2, 255-260;
© Springer Science+Business Media B.V. 2011
Dr. Lombardi has published about 40 articles in peer reviewed journals, dealing with brain
tumors, hepacellular carcinoma, genitourinary cancers, gynecological cancer and other adult
tumors.
TOTAL IMPACT FACTOR= 91.8, TOTAL H INDEX= 6 (SCOPUS, MARCH 2014)
G. Lombardi, F. Zustovich, P. Farina, A. Della Puppa, R. Manara, D. Cecchin, A. Brunello, A.
Cappetta, V. Zagonel. Neoplastic Meningitis from Solid Tumors: New Diagnostic and
Therapeutic Approaches. The Oncologist (2011); 16:1175-1188
IF 4.09
G. Lombardi, F. Zustovich, F. Farinati, U. Cillo, A. Vitale, G. Zanus, M. Donach, M. Farina, S.
Zovato, D. Pastorelli. Pegylated liposomal Doxorubicin and Gemcitabine in Patients With
Advancend Hepatocellular Carcinoma. Cancer (2011); 117: 125-33.
IF 5.2
G. Lombardi, F. Zustovich, P. Farina, P. Fiduccia, A. Della Puppa, V. Polo, R.Bertorelle, M.
P.Gardiman, A. Banzato, P. Ciccarino, L. Denaro, V. Zagonel Hypertension as a biomarker in
patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center
experience and a critical review of the literature. Anti-Cancer Drug (2013); 24:90-97
IF 2.23
G. Lombardi, E. Ruminato, R. Bertorelle, D. Saggioro, P. Farina, A. Della Puppa, F. Zustovich,
F. Berti, V. Sacchetto, R. Marcato, A. Amadori, V. Zagonel. Clinical and Genetic Factors
Associated With severe Hematological Toxicity in Glioblastoma Patients During Radiation Plus
Temozolomide Treatment. A prospective study. Am J Clin Onc (2013); Sep 21 (Epub ahead of
print). DOI: 10.1097/COC.0b013e3182a790ea
IF 2.55
G. Lombardi, F. Zustovich, M. Donach, M. Dalla Palma, O. Nicoletto, D. Pastorelli.An update on
targeted therapy in metastatic ranal cell carcinoma. Urologic Oncology: Seminars and Original
Investigations (2012); 30: 240-246
IF 3.64
G. Lombardi, F. Zustovich, P. Farina, V. Polo, M. Farina, A. Della Puppa, R. Bertorelle, M. P.
Gardiman, F. Berti, V. Zagonel. Cilengitide in bevacizumab-refractory high-grade glioma: two
case reports and critical review of the literature. Anti-Cancer Drugs (2012); 23:749-753
IF 2.23
G. Lombardi, M. O.Nicoletto, M. Gusella, P. Fiduccia, M. Dalla Palma, A. Zuin, D. Fiore, M.
Donach, V. Zagonel. Intrapleural paclitaxel for malignant pleural effusion from ovarion and
breast cancer: a phase II study with pharmacokinetic analysis. Cancer Chemother Pharmacol
(2012) 69:781-787 IF 2.79
G. Lombardi, F. Zustovich, A. Della Puppa, L. Borgato, E. Orvieto, R. Manara, D. Cecchin, F.
Berti, P. Farina, M. P. Gardiman, R. Scienza, V. Zagonel. Cisplatin and Temozolomide
combination in the treatment of leptomeningeal carcinomatosis from ethmoid sinus intestinaltype adenocarcinoma. J Neurooncol (2011); 1041:381-386. IF 3.11
G. Lombardi, F. Zustovich, M. O. Nicoletto, M. Donach, G. Artioli, D. Pastorelli. Diagnosis and
Tratment of Malignant Pleural Effusion. A systematic Literature Review and New Approaches.
American Journal of Clinical Oncology (2010); 33:420-3. IF 2.55
D. Pastorelli, F. Zustovich, G. Faggioni, S. Zovato, M. Donach, O. Nicoletto, M. Farina, L. Furini,
R. Ceravolo, P. Carli, G. Lombardi. Good response to second-line bevacizumab and interferonα in a sunitinib-refractory patient with metastatic renal cell carcinoma. Anti-cancer Drugs (2010)
21:210-213 IF 2.23
G. Lombardi, F. Zustovich, MO Nicoletto, M. Donach, D. Pastorelli. Important role of thiamine in
preventing ifosfamide-induced encephalopathy. J Oncol Pharm Practice (2010); 16: 135-136
G. Lombardi, F. Zustovich, S. Zovato, D. Fiore, A. Cappetta, D. Pastorelli. Characteristics and
management of pancreatic lesion in Von Hippel-Lindau disease: a systematic literature review.
Oncol Rev (2009); 3:103-106
G. Lombardi, A. Pambuku, L. Bellu, A. Della Puppa, L. Rumanò, M. P. Gardiman, F. Pomerri, V.
Zagonel. Cisplatin and temozolomide combination in the treatment of supratentorial anaplastic
ependymoma. Chemotherapy (2013) ; 31 :59(3):176-180. [Epub ahead of print] IF 2.06
F. Zustovich, G. Lombardi, O. Nicoletto, D. Pastorelli. Second-line therapy for refractory renalcell carcinoma. Critical Reviews in Oncology/Hematology (2012); 83:112-122. IF 4.63
Vitale, G. Lombardi, R. Ramirez Morales, U. Cillo. Potential impact of sorafenib on the survival
benefit of liver transplantation for hepatocellular carcinoma. Digestive and Liver Disease (2012);
44: 361-362. IF 3.16
F. Zustovich, G. Lombardi, P. Farina. Treating patients with metastatic renal carcinoma: an
escape from Phase III. Expert Rev. Anticancer Ther. (2012); 12(7): 919-927.IF 2.06
F. Zustovich, G. Lombardi, D. Pastorelli, P. Farina, L. Furini, R. Manara, M. Dalla Palma, A.
Rotilio, O.Nicoletto, V. Zagonel. Bevacizumab and Glioblastomas, a Single-Centre Experience:
How Disease History and Characteristics May Affect Clinical Outcome. Anticancer Research
(2010); 30:5213-5216. IF 1.7
M. Dalla Palma, G. Lombardi, M.E. Donach, L.Borgato, F. Zustovich, L. Furini, M. O. Nicoletto.
Tolerability of PLD/Oxaliplatin Regimen in Recurrent Ovarian Cancer Patients With Previous
Fragility to Carboplatin/Paclitaxel treatment. Am J Clin Onc (2011); 34(3): 305-8. IF 2.55
Zustovich F., Lombardi G., Cartei G. Paraneoplastic diffuse cutaneous papillomatosis. J Eur
Acad Dermatol Venerol (2009); 23(2): 220-1IF 2.69
F. Zustovich, G. Lombardi, D. Pastorelli. Important role of gemcitabine in the treatment of
classic Kaposi’s sarcoma. Tumori (2009); 95: 562-563. IF 0.92
F. Zustovich, G. Lombardi, A. Della Puppa, A. Rotilio, R. Scienza, D. Pastorelli. A Phase II
Study of Cisplatin and Temozolomide in Heavily Pre-treated Patients with Temozolomiderefractory High-grade Malignant Glioma. Anticancer Research (2009); 23:4275-4280. IF 1.7
F. Zustovich, G. Lombardi, N. Amirouchene, D. Pastorelli. Adult high-grade malignant gliomas.
Oncol Rev (2008) 2:233-237.
F. Zustovich, A. Ferro, G. Lombardi, V. Zagonel, P. Fiduccia, P. Farina. Bevacizumab as Frontline Treatment of Brain Metastases from Solid Tumors: A Case Serie. Anticancer Research
(2013); 33:4061-4066. IF 1.7
P. Farina, G. Lombardi, M. Rossetto, A. Alentorn, M. Sanson. Oligodendroglial tumors: from
biology to a better patient care. Reviews in Oncology (2013); 1 (1): 15-20.
F. Zustovich, L. Landi, G. Lombardi, C. Porta, L. Galli, A.Fontana, D. Amoroso, C. Galli, M.
Andreuccetti, A. Falcone, V. Zagonel. Sorafenib plus Daily Low-dose Temozolomide for
Relapsed Glioblastoma: A Phase II Study. Anticancer Research (2013); 33:3487-3494. IF 1.7
Della Puppa, S. De Pellegrin, E. D’Avella, G. Gioffrè, M. Rossetto, A. Gerardi, G. Lombardi, R.
Manara, M. Munari, M. Saladini, R. Scienza. 5-aminolevulinic acid (5-ALA) fluorescence guided
surgery of high-grade gliomas in eloquent areas asisted by functional mapping. Our experience
and review of the literature. Acta Neurochir (2013) 155:965-972. IF 1.54
Cappetta, S. Lonardi, D.Pastorelli, F. Bergamo, G. Lombardi, V. Zagonel. Advanced gastric
cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted terapies.
Critical Reviews in Oncology/Hematology 81 (2012) 38-48. IF 4.63
Vitale, P. Boccagni, X. Kertusha, G. Zanus, F. D’Amico, E. Lodo, D. Pastorelli, R. Ramirez
Morales, G. Lombardi, M. Senzolo, P. Burra, U. Cillo. Sorafenib for the Treatment of Recurrent
Hepatocellular Carcinoma After Liver Transplantation?. Transplantation Proceedings (2012); 44,
1989-1991 IF 0.95
P. Ciccarino, A. Rotilio, M. Rossetto, R. Manara, E. Orvieto, F. Berti, G. Lombardi, D. D’Avella,
R. Scienza, A. Della Puppa. Multifocal presentation of medulloblastoma in adulthood. J
Neurooncol (2012) 107:233-237. IF 3.11
F. Zustovich, G. Lombardi, D. Pastorelli, P. Farina, M. Dal Bianco, L. De Zorzi, M. Dalla Palma,
O.Nicoletto, V. Zagonel. Clinical experience and critical evaluation of the role of sorafenib in
renal cell carcinoma. Open Access Journal of Urology (2011); 3: 69-82
G. Artioli, M. Cassaro, L. Pedrini, L. Borgato, L. Corti, A. Cappetta, G. Lombardi, M.O. Nicoletto.
Rare presentation of endometrial carcinoma with singular bone metastasis. European Journal of
Cancer Care (2010); 19, 694-698. IF 1.3
M.O. Nicoletto, A. Parenti, P. Del Bianco, G. Lombardi, L. Pedrini, S. Pizzi, P. Carli, M. Dellla
Palma, D.Pastorelli, L. Corti, L. Becagli. Vulvar Cancer: Prognostic Factors. Anticancer
Research (2010); 30:2311-2318. IF 1.7
M. O. Nicoletto, R. Bertorelle, L. Borgato, G. L. De Salvo, G. Artioli, G. Lombardi, F. Zustovich,
R. Marcato, A. Parenti, M. Montagna, M. E. Donach. Family History of Cancer Rather Than p 53
Status Predicts Efficacy of Pegylated liposomal Doxorubicin and Oxaliplatin in Relapsed Ovarian
Cancer. Int J Gynecol Cancer (2009); 19 (6): 1022-8. IF 1.94
F. Zustovich, M. Shams, P. Anselmi, G. Lombardi, D. Pastorelli, G. Cartei. Cognitive and
emotive state in elderly treatment-naive patients with advanced cancer compared with an elderly
healthy control population. Cancer Therapy Vol 7 (2009) 149-154
Colombatti R., Calò A., Iacopetti T., Rosolen A., Lombardi G., Cesaro S. Successful treatment
of Severe Iatrogenic Calcinosis Cutis with Intravenous Sodium Thiosulfate in a Child Affected by
T-Acute Lymphoblastic Leukemia. Pediatric Dermatology (2009) Vol. 26 No. 3 311-315 IF 1.04
F. Ceccato, G. Occhi, D. Regazzo, M.L. Randi, D. Cecchin, M. P. Gardiman. R. Manara, G.
Lombardi, L. Denaro, F. Mantero, C. Scaroni. Gonadotropin secreting pituitary adenoma
associated with erythrocytosis: case report and literature review. Hormones (2014), 13(1): 131139 IF 2.49
Della Puppa A, Rustemi O, Gioffrè G, Troncon I, Lombardi G, Rolma G, Sergi M, Munari M,
Cecchin D, Gardiman MP, Scienza R. Predictive value of intraoperative 5-aminolevulinic acidinduced fluorescence for detecting bone invasion in meningioma surgery. J Neurosurgery 2014
Jan 10 (epub ahead of print) IF 3.14
D. Cecchin, I. Schiorlin, A. Della Puppa, Lombardi G. et al, Assessing Response Using -MIBI
Early after Interstitial Chemotherapy with Carmustine-Loaded Polymers in Glioblastoma
Multiforme: Preliminary Results, BioMed Research International, vol. 2014, Article ID 684383, 6
pages, 2014. doi:10.1155/2014/684383 IF 2.88
Giuseppe Lombardi, Patrizia Farina, Alessandro Della Puppa, et al., An Overview of
Fotemustine in High-Grade Gliomas: From Single Agent to Association with
Bevacizumab, BioMed Research International, vol. 2014, Article ID 698542, 8 pages, 2014.
doi:10.1155/2014/698542 IF 2.88
Giuseppe Lombardi, Alessandro Della Puppa, Fable Zustovich, et al., “The Combination of
Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional
Experience, BioMed Research International, vol. 2014, Article ID 678191, 4 pages, 2014.
doi:10.1155/2014/678191 IF 2.88
Alessandro Della Puppa, Pietro Ciccarino, Giuseppe Lombardi, Giuseppe Rolma, Diego
Cecchin, and Marta Rossetto. 5-Aminolevulinic Acid Fluorescence in High Grade Glioma
Surgery: Surgical Outcome, Intraoperative Findings, and Fluorescence Patterns, BioMed
Research International, vol. 2014, Article ID 232561, 8 pages, 2014. doi:10.1155/2014/232561
IF 2.88
Patrizia Farina, Giuseppe Lombardi, Eleonora Bergo, Anna Roma, Vittorina Zagonel.
Treatment of malignant gliomas in elderly patients: a coincise overview of the literature. BioMed
Research International, vol. 2014, Article ID 734281, 9 pages, 2014. doi: 10.1155/2014/734281
IF 2.88
Scientific affiliations
ITALIAN ASSOCIATION OF MEDICAL ONCOLOGY-AIOM
EUROPEAN SOCIETY OF MEDICAL ONCOLOGY-ESMO
AMERICAN SOCIETY OF MEDICAL ONCOLOGY-ASCO
EUROPEAN ASSOCIATION OF NEURO-ONCOLOGY- EANO
EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC) – BRAIN TUMOR
GROUP
ASSOCIAZIONE ITALIANA DI NEURO-ONCOLOGIA - AINO